Bayer Investor Relations

Team having a chat
Investor News
Share Price / Index
May 13, 2025
First-quarter performance:
Bayer confirms 2025 targets after solid start to the year
May 09, 2025
Not intended for U.S. and UK Media
Aflibercept 8 mg to treat macular edema following retinal vein occlusion submitted for approval in Japan
April 25, 2025
CEO Bill Anderson at the Annual Stockholders’ Meeting:
“We’re working at full force to put Bayer back on a profitable growth path”